Lewis Karen

Chief People Officer

1 company

Excellent

Trades Analyzed

12M Win Rate

80.0%

Avg 3M Return

+12.1%

Avg 12M Return

+30.8%

Lewis Karen is a Chief People Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.

Estimated insider holdings value: $2.9M based on current market prices.

Holdings by Company

APLSJan 29, 2025

Current Shares70.3K

Value$2.88M

Net Activity-32,079

Bought: 0Sold: 32.1K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 29, 2025	APLS Apellis Pharmaceuticals, Inc.	Chief People Officer	Sell	364	$29.52	$10,746.59	-0.5%	-38.2%	-21.8%
Jan 22, 2025	APLS Apellis Pharmaceuticals, Inc.	Chief People Officer	Sell	1,751	$30.43	$53,275.05	-2.4%	-42.8%	-27.6%
Jan 17, 2025	APLS Apellis Pharmaceuticals, Inc.	Chief People Officer	Sell	1,241	$29.96	$37,178.13	-2.8%	-39.2%	-33.4%
Jan 13, 2025	APLS Apellis Pharmaceuticals, Inc.	Chief People Officer	Sell	1,599	$28.70	$45,894.66	-3.4%	-32.4%	-25.4%
Jan 30, 2024	APLS Apellis Pharmaceuticals, Inc.	Chief People Officer	Sell	1,250	$65.12	$81,401.71	-1.3%	-27.5%	-55.3%
Jan 23, 2024	APLS Apellis Pharmaceuticals, Inc.	Chief People Officer	Sell	4,286	$63.69	$272,975.34	-8.3%	-28.0%	-54.1%
Jan 22, 2024	APLS Apellis Pharmaceuticals, Inc.	Chief People Officer	Sell	1,738	$65.00	$112,963.05	-3.2%	-27.2%	-54.0%
Jan 17, 2024	APLS Apellis Pharmaceuticals, Inc.	Chief People Officer	Sell	3,276	$65.58	$214,840.08	-5.8%	-21.4%	-54.9%
Jan 16, 2024	APLS Apellis Pharmaceuticals, Inc.	Chief People Officer	Sell	1,632	$66.81	$109,031.64	-2.8%	-22.3%	-56.2%
Jun 1, 2023	APLS Apellis Pharmaceuticals, Inc.	Chief People Officer	Sale+OE	5,000	$86.00	$430,000.00	-10.8%	-53.5%	-55.0%